Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
Guy Hans1,2, Dominique Robert3, Johanna Verhulst2, Marcel Vercauteren1,21Department of Anesthesiology, 2Multidisciplinary Pain Center, 3Department of Intensive Care, Antwerp University Hospital, Edegem, BelgiumAbstract: Neuropathic pain (NeP) syndromes remain a difficult-to-treat medical entity. Des...
Guardado en:
Autores principales: | Guy Hans, Dominique Robert, Johanna Verhulst, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/20d456d711354677afaf1faa87794520 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-dose fentanyl sublingual spray for breakthrough cancer pain
por: Taylor DR
Publicado: (2013) -
Transdermal Patches for Delivery of Beta-Blockers
por: Rohaľová S., et al.
Publicado: (2021) -
Retraction Notice to: circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway
por: Guojun Wu, et al.
Publicado: (2021) -
Investigation of pulmonary infection pathogens in neurological intensive care unit
por: Fengying Quan, et al.
Publicado: (2011) -
Intrathecal interleukin-1β decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain
por: Sheu-Ran Choi, et al.
Publicado: (2021)